J&J pulls morcellator from market

Share this article:

Johnson & Johnson is pulling its power morcellator tool from the market, reports the Star-Ledger. The device is used in hysterectomies and in fibroid removal procedures. Although the device was operating as intended, recent scrutiny indicates that the tool may spread cancers during the process.

J&J's Ethicon division stopped selling the morcellator in April, but is now asking doctors to return them. The Star-Ledger and the Washington Post (via Reuters) say J&J is calling this move a withdrawal, instead of a recall.

Time notes (via the WSJ) that the device is not a major earner for J&J, but it dominates 72% of the market.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.

Study says statins not enough for diabetic hearts

Researchers using an experimental test have discovered that the 50% of surveyed diabetics may also have undetected heart muscle damage.